When.com Web Search

  1. Ads

    related to: famotidine vs zantac

Search results

  1. Results From The WOW.Com Content Network
  2. Famotidine - Wikipedia

    en.wikipedia.org/wiki/Famotidine

    Famotidine, sold under the brand name Pepcid among others, is a histamine H 2 receptor antagonist medication that decreases stomach acid production. [4] It is used to treat peptic ulcer disease , gastroesophageal reflux disease , and Zollinger–Ellison syndrome . [ 4 ]

  3. Sanofi to settle 4,000 lawsuits claiming Zantac is linked to ...

    www.aol.com/sanofi-settle-4-000-lawsuits...

    Sanofi discontinued the ranitidine formulation of Zantac, and the new formulation, Zantac 360, is made with famotidine, a different active ingredient.

  4. Ranitidine - Wikipedia

    en.wikipedia.org/wiki/Ranitidine

    Ranitidine, previously sold under the brand name Zantac [a] among others, is a medication used to decrease stomach acid production. [12] It was commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. [12] It can be given by mouth, injection into a muscle, or injection into a vein.

  5. H2 receptor antagonist - Wikipedia

    en.wikipedia.org/wiki/H2_receptor_antagonist

    Cimetidine was the prototypical histamine H 2 receptor antagonist from which later drugs were developed. Cimetidine was the culmination of a project at Smith, Kline & French (SK&F; now GlaxoSmithKline) by James W. Black, C. Robin Ganellin, and others to develop a histamine receptor antagonist that would suppress stomach acid secretion.

  6. Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

    www.aol.com/news/sanofi-settle-4-000-zantac...

    NEW YORK (Reuters) -Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did ...

  7. GSK asks to appeal Delaware ruling allowing Zantac cases to ...

    www.aol.com/news/latest-trial-over-zantac-cancer...

    First approved in 1983, Zantac became the world's best-selling medicine in 1988 and one of the first to top $1 billion in annual sales. It was originally marketed by a forerunner of GSK and later ...